We are working with a site that will participate in a clinical trial and the investigators have proposed to work with two principal investigators, instead of a single one. This has raised a lot of debate in our team, we are not sure if it is acceptable from a regulatory point of view. And if so, we would like to know what it implies in terms of ICH compliance as we can imagine that both PIs might need to divide their responsibilities and leave some register of this agreement.
Thanks in advance for your views.